Sudhir Srivastava is chief of the Cancer Biomarkers Research Group of the Division of Cancer Prevention at the United States NCI. Srivastava has held this position since 2000. He is a co-author of the Bethesda Guidelines for the diagnosis of Hereditary non-polyposis colorectal cancer (HNPCC). Srivastava is an elected member of the

American Joint Committee on Cancer The American Joint Committee on Cancer (AJCC) is an organization best known for defining and popularizing cancer staging standards, officially the AJCC staging system. The American Joint Committee on Cancer (AJCC) was established in 1959 to formul ...

(AJCC), responsible for developing cancer staging criteria, and serves on the AJCC Executive Committee and the All Ireland-NCI Consortium. Srivastava is a founding member of

HUPO The Human Proteome Organization (HUPO) is an international consortium of national proteomics research associations, government researchers, academic institutions, and industry partners. The organization was launched in February 2001, and it promotes ...

, participated in the Plasma Proteome and the Liver Proteome Projects, and supported several HUPO-supported initiatives.

References

{{DEFAULTSORT:Srivastava, Sudhir Living people American medical researchers Banaras Hindu University alumni Virginia Commonwealth University alumni Johns Hopkins University alumni University of California, San Francisco faculty University of Arizona faculty Cancer researchers 1954 births